Literature DB >> 25075718

Adjuvant-active fraction from Albizia julibrissin saponins improves immune responses by inducing cytokine and chemokine at the site of injection.

Hongxiang Sun1, Shuwang He2, Minghua Shi2.   

Abstract

The total saponin from the stem bark of Albizia julibrissin (AJSt) has previously showed the adjuvant potentials in mice. In this study, AJSt was subjected to resin column chromatography to afford four fractions (AJS30, AJS50, AJS75 and AJS95), and these fractions were further compared for the hemolytic activities and adjuvant potentials on the immune response to ovalbumin (OVA) and recombinant fowl pox virus vector-based avian influenza vaccine (rFPV). AJSt, AJS50, AJS75 and AJS95 showed a slight hemolytic effect. AJSt, AJS50 and AJS75 significantly enhanced not only the concanavalin A (Con A)-, lipopolysaccharide (LPS)- and antigen-stimulated splenocyte proliferation, but also serum antigen-specific IgG, IgG1, IgG2a and IgG2b antibody titers in the mice immunized with OVA and rFPV. AJSt, AJS50 and AJS75 also significantly promoted the NK cell activity and delayed-type hypersensitivity (DTH) in the OVA-immunized mice. Furthermore, the mechanisms of adjuvant action were explored by determining the effects of AJS75 on cytokines and chemokines at the site of injection using antibody array. AJS75 induced or up-regulated the protein expression of 12 cytokines (IL-12p40, IL-12p40/p70, IFN-γ, IL-13, IL-1β, IL-6, IL-10, TNF-α, sTNFR I, sTNFR III, IL-3 and IL-9) and 10 chemokines (Eotaxin, I-TAC, MIG, MIP-1α, RANTES, TECK, Fracatlkine, FasL, M-CSF and GM-CSF) in the injected muscles. The results suggested that AJS75, the most adjuvant-active fraction of AJSt, could improve antigen-specific both cellular and humoral immune responses and simultaneously elicit a Th1/Th2 response by inducing cytokine and chemokine at the site of injection.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Active fraction; Adjuvant; Albizia julibrissin; Cytokines and chemokines; Mechanisms; Saponin

Mesh:

Substances:

Year:  2014        PMID: 25075718     DOI: 10.1016/j.intimp.2014.07.021

Source DB:  PubMed          Journal:  Int Immunopharmacol        ISSN: 1567-5769            Impact factor:   4.932


  8 in total

Review 1.  Compounds with anti-influenza activity: present and future of strategies for the optimal treatment and management of influenza. Part II: Future compounds against influenza virus.

Authors:  R Gasparini; D Amicizia; P L Lai; N L Bragazzi; D Panatto
Journal:  J Prev Med Hyg       Date:  2014-12

2.  Antiviral and Immunoregulatory Role Against PCV2 in Vivo of Chinese Herbal Medicinal Ingredients.

Authors:  Haifeng Yang; Xiaolan Chen; Chunmao Jiang; Kongwang He; Yiyi Hu
Journal:  J Vet Res       Date:  2017-12-27       Impact factor: 1.744

3.  Mechanisms of Mixed Th1/Th2 Responses in Mice Induced by Albizia julibrissin Saponin Active Fraction by in Silico Analysis.

Authors:  Jing Du; Junjie Jin; Juanjuan Wang; Hongxiang Sun
Journal:  Vaccines (Basel)       Date:  2020-01-27

4.  Quick and improved immune responses to inactivated H9N2 avian influenza vaccine by purified active fraction of Albizia julibrissin saponins.

Authors:  Hongxiang Sun; Liyan Fei; Binnian Zhu; Minghua Shi
Journal:  BMC Vet Res       Date:  2020-11-07       Impact factor: 2.741

Review 5.  Substantial effect of phytochemical constituents against the pandemic disease influenza-a review.

Authors:  A Brindha Devi; R Sarala
Journal:  Futur J Pharm Sci       Date:  2021-06-12

6.  Immunological adjuvant effect of the peptide fraction from the larvae of Musca domestica.

Authors:  Liqing Chen; Juan Zhang; Hongxiang Sun
Journal:  BMC Complement Altern Med       Date:  2015-12-02       Impact factor: 3.659

7.  The Adjuvant Activity of Epimedium Polysaccharide-Propolis Flavone Liposome on Enhancing Immune Responses to Inactivated Porcine Circovirus Vaccine in Mice.

Authors:  Yunpeng Fan; Liwei Guo; Weifeng Hou; Chao Guo; Weimin Zhang; Xia Ma; Lin Ma; Xiaoping Song
Journal:  Evid Based Complement Alternat Med       Date:  2015-11-03       Impact factor: 2.629

8.  Application of red clover isoflavone extract as an adjuvant in mice.

Authors:  Hongbo Chen; Xue Zhang; Longsi Liu; Mingqin Cai; Zhijun Guo; Longxin Qiu
Journal:  Exp Ther Med       Date:  2019-12-11       Impact factor: 2.447

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.